MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

94.28 +1.12 (+1.20%)
Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Boeing, Uber, Delta Air Lines And A Health Care Stock On CNBC's 'Final Trades' ↗
Stephanie Link, chief investment strategist and portfolio manager at Hightower, picked The Boeing Company as her final trade. 
Via Benzinga
News headline image
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
From Monogram Technologies Inc.
Via GlobeNewswire
News headline image
Breaking Down Zimmer Biomet Holdings: 11 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Top S&P500 movers in Monday's pre-market session ↗
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
How Is The Market Feeling About Zimmer Biomet Holdings? ↗
 
Via Benzinga
News headline image
3 Healthcare Stocks with Questionable Fundamentals
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - A Reliable Dividend Stock Worth Considering ↗
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) offers a reliable dividend with strong profitability and reasonable valuation, making it a candidate for income investors. 
Via Chartmill
News headline image
1 Profitable Stock to Target This Week and 2 to Approach with Caution
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
Peering Into Zimmer Biomet Holdings's Recent Short Interest ↗
 
Via Benzinga
News headline image
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - An Undervalued Stock Worth Considering ↗
ZIMMER BIOMET (NYSE:ZBH) is an undervalued medical device stock with strong profitability, a reasonable dividend, and improving growth prospects. A solid pick for value investors. 
Via Chartmill
News headline image
3 Out-of-Favor Stocks with Questionable Fundamentals
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
News headline image
2 Mid-Cap Stocks to Consider Right Now and 1 to Question
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
Via StockStory
News headline image
Zimmer Biomet Holdings Inc (NYSE:ZBH) - A Reliable Dividend Stock Worth Considering ↗
Zimmer Biomet Holdings (NYSE:ZBH) offers a reliable dividend with strong profitability and reasonable valuation, making it a solid pick for income investors. 
Via Chartmill
News headline image
3 S&P 500 Stocks Facing Headwinds
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
News headline image
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
From Treace Medical Concepts, Inc.
Via GlobeNewswire
News headline image
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - An Undervalued Stock With Solid Fundamentals ↗
ZIMMER BIOMET HOLDINGS (NYSE:ZBH) is an undervalued medical device stock with strong profitability, reasonable debt, and improving growth prospects, making it a candidate for value investors. 
Via Chartmill
News headline image
A Look Back at Surgical Equipment & Consumables - Diversified Stocks’ Q1 Earnings: Zimmer Biomet (NYSE:ZBH) Vs The Rest Of The Pack
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Zimmer Biomet Holdings Inc (NYSE:ZBH) - A Reliable Dividend Stock Worth Considering ↗
Zimmer Biomet Holdings (NYSE:ZBH) offers a reliable dividend with strong profitability and decent financial health, making it a candidate for income investors. 
Via Chartmill
News headline image
Gapping S&P500 stocks in Monday's session ↗
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
ZBH Q1 Earnings Call: Revenue Tops Expectations, Guidance Lowered Amid Tariff and Integration Headwinds
Medical device company Zimmer Biomet (NYSE:ZBH) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 1.1% year on year to $1.91 billion. Its non-GAAP profit of $1.81 per... 
Via StockStory
Topics Economy World Trade
News headline image
Assessing Zimmer Biomet Holdings: Insights From 10 Financial Analysts ↗
 
Via Benzinga
News headline image
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. ↗
ZIMMER BIOMET HOLDINGS INC has a stellar value proposition. NYSE:ZBH not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. 
Via Chartmill
News headline image
These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results ↗
 
Via Benzinga
News headline image
Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal ↗
Zimmer Biomet Q1 sales rose 1.1% to $1.91 billion; FY25 EPS outlook trimmed but revenue growth forecast lifted following Paragon 28 acquisition. 
Via Benzinga
News headline image
What's going on in today's session: S&P500 movers ↗
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday. 
Via Chartmill
News headline image
Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday? ↗
Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services... 
Via Benzinga
News headline image
Why Zimmer Biomet (ZBH) Stock Is Trading Lower Today
Shares of medical device company Zimmer Biomet (NYSE:ZBH) fell 10.2% in the afternoon session after the company reported underwhelming first quarter 2025 results as it lowered its full-year EPS... 
Via StockStory
Topics Artificial Intelligence
News headline image
These S&P500 stocks have an unusual volume in today's session ↗
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below. 
Via Chartmill
News headline image
Services Activity Barely Expands In April As Price Pressures Spike To Over 2-Year Highs: 'A Worrying Backstory Is Developing' ↗
US services sector growth slows in April. Inflationary pressures surge to a 2-year high, driven by trade tariffs. Stalling momentum and stagflation risks loom. 
Via Benzinga
Topics Economy World Trade
News headline image
Which S&P500 stocks are moving on Monday? ↗
Stay updated with the movements of the S&P500 index in the middle of the day on Monday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story